![Hans-Peter Gerber](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Hans-Peter Gerber
Chief Tech/Sci/R&D Officer at
SUTRO BIOPHARMA, INC.
Net worth: 324 298 $ as of 2026-06-29
Profile
Hans-Peter Gerber currently works at T-CURX GmbH, as Chairman and Sutro Biopharma, Inc., as Chief Scientific Officer from 2023.
Dr. Gerber also formerly worked at NBE-Therapeutics AG, as Independent Director from 2017 to 2021 and Maverick Therapeutics, Inc., as President, Director & Chief Science Officer from 2016 to 2018.
Dr. Gerber received his graduate degree and doctorate degree from the University of Zurich.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-03-30 | 9,768 ( 0.06% ) | 324 298 $ | 2026-06-29 |
Hans-Peter Gerber active positions
| Companies | Position | Start |
|---|---|---|
| SUTRO BIOPHARMA, INC. | Chief Tech/Sci/R&D Officer | 2023-09-17 |
T-CURX GmbH
 T-CURX GmbH BiotechnologyHealth Technology Operates as a biotech company that develops immunotherapies to treat cancer | Chairman | - |
Former positions of Hans-Peter Gerber
| Companies | Position | End |
|---|---|---|
NBE-Therapeutics AG
 NBE-Therapeutics AG Pharmaceuticals: MajorHealth Technology Develops antibody drug conjugates and advancing targeted cancer therapies | Director/Board Member | 2020-12-31 |
Maverick Therapeutics, Inc.
 Maverick Therapeutics, Inc. BiotechnologyHealth Technology Operates as a preclinical stage biotech company which develops T cell redirecting antibody therapeutics | President | 2017-12-31 |
Training of Hans-Peter Gerber
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
42
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Sutro Biopharma, Inc.
 Sutro Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops new products in protein vaccines and therapeutics | Health Technology |
University of Zurich
 University of Zurich Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NBE-Therapeutics AG
NBE-Therapeutics AG Pharmaceuticals: MajorHealth Technology Develops antibody drug conjugates and advancing targeted cancer therapies | Health Technology |
Maverick Therapeutics, Inc.
Maverick Therapeutics, Inc. BiotechnologyHealth Technology Operates as a preclinical stage biotech company which develops T cell redirecting antibody therapeutics | Health Technology |
T-CURX GmbH
T-CURX GmbH BiotechnologyHealth Technology Operates as a biotech company that develops immunotherapies to treat cancer | Health Technology |
- Stock Market
- Insiders
- Hans-Peter Gerber
